{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T16:15:31Z","timestamp":1760890531666,"version":"3.37.3"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100026749","name":"The Bar Association of San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100026749","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejpb.2024.114230","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T16:30:33Z","timestamp":1708187433000},"page":"114230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Assessing Abuse-Deterrent formulations utilizing Ion-Exchange resin complexation processed via Twin-Screw granulation for improved safety and effectiveness"],"prefix":"10.1016","volume":"197","author":[{"given":"Siva","family":"Ram Munnangi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagarjuna","family":"Narala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preethi","family":"Lakkala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sateesh","family":"Kumar Vemula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Repka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114230_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.02.006","article-title":"Development and impact of prescription opioid abuse deterrent formulation technologies","volume":"138","author":"Alexander","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejpb.2024.114230_b0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41120-017-0014-9","article-title":"A review of in vivo and in vitro aspects of alcohol-induced dose dumping","volume":"3","author":"D\u2019Souza","year":"2017","journal-title":"AAPS Open"},{"key":"10.1016\/j.ejpb.2024.114230_b0015","doi-asserted-by":"crossref","unstructured":"A. Butreddy, D. Nyavanandi, S. Narala, F. Austin, S. Bandari, Application of Hot Melt Extrusion Technology in the Development of Abuse-Deterrent Formulations: An Overview, Curr. Drug Deliv. 18. 4\u201318.","DOI":"10.2174\/1567201817999200817151601"},{"key":"10.1016\/j.ejpb.2024.114230_b0020","doi-asserted-by":"crossref","unstructured":"D. Rana, S. Salave, D. Benival, Emerging Trends in Abuse-Deterrent Formulations: Technological Insights and Regulatory Considerations, Curr. Drug Deliv. 19. 846\u2013859.","DOI":"10.2174\/1567201818666211208101035"},{"journal-title":"US Food Drug Adm","year":"2022","author":"Abuse-Deterrent Opioids-Evaluation","key":"10.1016\/j.ejpb.2024.114230_b0025"},{"key":"10.1016\/j.ejpb.2024.114230_b0030","unstructured":"G. Nilhalani, Extended-Release Abuse Deterrent Formulation of an Opioid Analgesic, (2023)."},{"key":"10.1016\/j.ejpb.2024.114230_b0035","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-023-03517-w","article-title":"Drug complexes: perspective from academic research and pharmaceutical market","author":"Munnangi","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2024.114230_b0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijpharm.2018.05.068","article-title":"Hot melt extrusion of ion-exchange resin for taste masking","volume":"547","author":"Tan","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114230_b0045","unstructured":"I. Ghebre-Sellassie, H. Terefe, Tamper-resistant pharmaceutical dosage forms and process for making same, US10010620B2, 2018."},{"key":"10.1016\/j.ejpb.2024.114230_b0050","article-title":"Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings","author":"Mehta","year":"2012","journal-title":"US8202542B1"},{"key":"10.1016\/j.ejpb.2024.114230_b0055","article-title":"Impact assessment of the variables affecting the drug release and extraction of polyethylene oxide based tablets","volume":"71","author":"Salem","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2024.114230_b0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/0269881120959615","article-title":"Beyond the \u2018purple drank\u2019: study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports","volume":"35","author":"Chiappini","year":"2021","journal-title":"J. Psychopharmacol. (oxf.)"},{"key":"10.1016\/j.ejpb.2024.114230_b0065","unstructured":"Bioavailability Studies Submitted in NDAs or INDs \u2013 General Considerations US Food Drug Adm. 2022."},{"key":"10.1016\/j.ejpb.2024.114230_b0070","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejpb.2011.04.003","article-title":"The influence of dissolution conditions on the drug ADME phenomena","volume":"79","author":"Cascone","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114230_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122430","article-title":"Stability of Abuse-deterrent properties of PEO-based Abuse-deterrent formulation","volume":"631","author":"Kibria","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114230_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120726","article-title":"Evaluation of the impact of abuse deterring agents on the physicochemical factors of tramadol-loaded tablet and the definition of new abuse deterrent index","volume":"605","author":"Won","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114230_b0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1517\/17425255.2015.979786","article-title":"Abuse-deterrent formulations: part 1 \u2013 development of a formulation-based classification system","volume":"11","author":"Mastropietro","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejpb.2024.114230_b0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2016.01.031","article-title":"Risk based in vitro performance assessment of extended release abuse deterrent formulations","volume":"500","author":"Xu","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114230_b0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejpb.2014.02.008","article-title":"The design of controlled-release formulations resistant to alcohol-induced dose dumping \u2013 A review","volume":"87","author":"Jedinger","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114230_b0100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10847-006-9247-2","article-title":"The complexation efficiency","volume":"57","author":"Loftsson","year":"2007","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ejpb.2024.114230_b0105","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/pharmaceutics13050668","article-title":"Continuous twin screw granulation: a review of recent progress and opportunities in formulation and equipment design","volume":"13","author":"Portier","year":"2021","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2024.114230_b0110","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/pharmaceutics10020068","article-title":"Twin screw granulation: effects of properties of primary powders","volume":"10","author":"Lute","year":"2018","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2024.114230_b0115","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1208\/s12249-008-9133-x","article-title":"Development of a melting tablet containing promethazine HCl against motion sickness","volume":"9","author":"Haware","year":"2008","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2024.114230_b0120","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.3390\/polym13244394","article-title":"Study on the complexation and release mechanism of methylphenidate hydrochloride ion exchange resin complex","volume":"13","author":"Li","year":"2021","journal-title":"Polymers."},{"key":"10.1016\/j.ejpb.2024.114230_b0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1208\/s12249-020-01824-8","article-title":"Structure-property relationship of amorphous maltitol as tableting excipient","volume":"21","author":"Bourduche","year":"2020","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2024.114230_b0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejpb.2009.04.006","article-title":"Development and characterization of extended release Kollidon\u00ae SR mini-matrices prepared by hot-melt extrusion","volume":"73","author":"\u00d6zg\u00fcney","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114230_b0135","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1007\/s10853-023-08598-x","article-title":"3D printing of hollow capsular body & sealing pin by fused filament fabrication (FFF) technique using Kollicoat MAE 100P filament for intestinal specific delivery","volume":"58","author":"Kotha","year":"2023","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.ejpb.2024.114230_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.117477","article-title":"Impact on micellization between promethazine hydrochloride and ester bonded gemini surfactant in distinct solvents: a multi-faceted procedure","volume":"342","author":"Abdul Rub","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2024.114230_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.118287","article-title":"Impact of numerous media on association, interfacial, and thermodynamic properties of promethazine hydrochloride (PMT) + benzethonium chloride (BTC) mixture of various composition","volume":"346","author":"Rub","year":"2022","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2024.114230_b0150","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/molecules28020748","article-title":"taste masking of promethazine hydrochloride using l-Arginine polyamide-based nanocapsules","volume":"28","author":"Alyami","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2024.114230_b0155","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1021\/jp9717554","article-title":"Vibrational Spectroscopy of NH4+ Ions in Zeolitic Materials: an IR Study","volume":"101","author":"Zecchina","year":"1997","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejpb.2024.114230_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.121357","article-title":"Micellization behavior of promethazine hydrochloride and dimethyldodecylethylammonium bromide mixture in distinctive media: a multi-technique study","volume":"375","author":"Abdul Rub","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2024.114230_b0165","doi-asserted-by":"crossref","unstructured":"NMR and FT-IR studies of sulfonated styrene-based homopolymers and copolymers, Polymer 43 (2002) 5125\u20135132.","DOI":"10.1016\/S0032-3861(02)00390-7"},{"key":"10.1016\/j.ejpb.2024.114230_b0170","article-title":"Formulation and evaluation of kollidon\u00ae SR for PH-independent extended release matrix systems for propranolol hydrochloride","author":"Mulani","year":"2011","journal-title":"In"},{"year":"2023","series-title":"Development of delayed-release pellets of Ibuprofen Using Kollicoat\u00ae MAE 100P via Hot-Melt Extrusion Technology","author":"Darji","key":"10.1016\/j.ejpb.2024.114230_b0175"},{"key":"10.1016\/j.ejpb.2024.114230_b0180","article-title":"Enhanced moisture barrier immediate release film coating systems and substrates coated therewith","author":"Farrell","year":"2010","journal-title":"US20100291183A1"},{"year":"2020","series-title":"General Principles for Evaluating the Abuse Deterrence of Generic Solid Oral Opioid Drug Products Guidance for Industry","key":"10.1016\/j.ejpb.2024.114230_b0185"},{"key":"10.1016\/j.ejpb.2024.114230_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119169","article-title":"3D printed opioid medicines with alcohol-resistant and abuse-deterrent properties","volume":"579","author":"Ong","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114230_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120622","article-title":"A study of Kollicoat\u00ae MAE100P film\u2019s structure and properties","volume":"606","author":"Li","year":"2021","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124000560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124000560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T19:42:08Z","timestamp":1738438928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124000560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":39,"alternative-id":["S0939641124000560"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114230","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing Abuse-Deterrent formulations utilizing Ion-Exchange resin complexation processed via Twin-Screw granulation for improved safety and effectiveness","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114230"}}